**Core Concept**
The question is testing the side effect profile of anticancer drugs, specifically their effects on coagulation. Certain chemotherapeutic agents can induce a hypercoagulable state, increasing the risk of thrombosis.

**Why the Correct Answer is Right**
The correct answer is likely to be a drug that affects the coagulation pathway, either by altering the levels of clotting factors or by inhibiting anticoagulant proteins. The anticancer drug **L-asparaginase** can cause a hypercoagulable state by decreasing the levels of antithrombin, a protein that inhibits thrombin and factor Xa. This leads to an increase in thrombin generation and a subsequent increase in clot formation.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not have a well-documented association with hypercoagulability.
* **Option B:** This option is incorrect because it is not known to affect the coagulation pathway in a way that would lead to a hypercoagulable state.
* **Option D:** This option is incorrect because it is not commonly associated with hypercoagulability.

**Clinical Pearl / High-Yield Fact**
Chemotherapy-induced thrombosis is a significant concern, and patients receiving anticancer therapy should be monitored for signs of thrombosis, such as swelling, pain, or shortness of breath.

**Correct Answer:** C. L-asparaginase. L-asparaginase can cause a hypercoagulable state by decreasing the levels of antithrombin.